Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis

Keyphrases

• 3 to 5 Years 20%
• Ataxia 20%
• Brainstem Function 20%
• Chemical Shift Imaging 20%
• Clinical Assessment 20%
• Clinical Course 100%
• Clinical Progression 20%
• Clinical Status 60%
• Disability 20%
• Disease Course 100%
• Disease Progression 100%
• Dynamic Alignment 20%
• Expanded Disability Status Scale 40%
• Frontal Region 20%
• Function Change 20%
• Gait 20%
• Glutathione 100%
• GSH Level 100%
• Imaging Techniques 20%
• Longitudinal Change 100%
• Motor Strength 20%
• Multiple Quantum Wells 20%
• Multiple Sclerosis 60%
• Neurologist 20%
• Oxidative Stress 60%
• Parietal Area 20%
• Pathogenic Process 20%
• Pathophysiology 20%
• Progressive multiple Sclerosis 100%
• Quantum Chemistry 20%
• Tremor 20%
• Vision Change 20%

Neuroscience

• Ataxia 20%
• Brainstem 20%
• Chemical Shift Imaging 20%
• Clinical Assessment 20%
• Expanded Disability Status Scale 40%
• Glutathione 100%
• Imaging Technique 20%
• Multiple Sclerosis 60%
• Oxidative Stress 60%
• Secondary Progressive Multiple Sclerosis 100%
• Tremor 20%